🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the long-term clinical outcomes and prognostic factors in patie...
Status
Recruiting
Location
Chonnam National University Hospital
Start Date
2021-11-01
Trial ID
NCT05124249
Treatments Being Tested
A Multicenter national longitudinal cohort study including at least 800 ind...
Status
Completed
Location
CHU d'Amiens
Start Date
2014-11-04
Trial ID
NCT02264899
Treatments Being Tested
Anatomical ophthalmological connections and their dynamics are still debate...
Status
Completed
Location
Hôpital Necker-Enfants Malades
Start Date
2021-05-19
Trial ID
NCT04886219
Treatments Being Tested
The purpose of this study is to evaluate the intraocular stability and safe...
Status
Completed
Location
Zentrum für Augenheilkunde
Start Date
2006-09
Trial ID
NCT00773266
The Atlas of Retinal Imaging in Alzheimer's (ARIAS) study is a 5-year study...
Status
Completed
Location
Morton Plant Hospital
Start Date
2019-12-16
Trial ID
NCT03862222
ApolloVue® S100 Image System is a medical device class II. The objective of...
Status
Completed
Location
Taipei Veterans General Hospital
Start Date
2020-07-06
Trial ID
NCT04406454
Treatments Being Tested
The purpose of this study is to evaluate the combined effects of diabetes s...
Status
Unknown
Location
Advantage Vision Center
Start Date
2020-01-01
Trial ID
NCT04120077
Treatments Being Tested
Prospective interventional study, open, non-comparative and non-randomized....
Status
Completed
Location
Hospices Civils de Lyon - Hopital de la Croix Rousse
Start Date
2018-10-04
Trial ID
NCT03739073
Treatments Being Tested
Primary Objective: To assess the efficacy of cenegermin-bkbj (20 mcg/mL) o...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-26
Trial ID
NCT06411145
Treatments Being Tested
Purpose: Study the effect of nepafenac ophthalmic suspension 0.1% to preven...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2007-06
Trial ID
NCT00494494
Treatments Being Tested